Consensus Edwards Lifesciences Corporation

Stocks

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - NYSE 01:30:03 01/09/2026 am IST			5-day change	1st Jan Change
90.75 ^USD	+0.60%		+0.28%	+6.45%

27/08	Edwards Lifesciences Insider Sold Shares Worth $2,894,440, According to a Recent SEC Filing	MT
21/08	Argus Adjusts Price Target on Edwards Lifesciences to $115 From $105, Maintains Buy Rating	MT

Evolution of the Average Target: Edwards Lifesciences Corporation

Evolution of the Target Price: Edwards Lifesciences Corporation

Changes in Analyst Recommendations: Edwards Lifesciences Corporation

d837d0fddeb79820c34c.syleUn1biw9hNXYpDpnKrktOhhNP_iJ7p7qslwFCP68.2RkwAQ8Uv0MVUCAQQa749jwdz0oNzndL0MnF-kYwd5r0TQkQHw3bbSpCBQ~fd77cdb394cb098b8915f6b39d01aa21

Analysts' recommendations: Edwards Lifesciences Corporation

21/08	Argus Adjusts Price Target on Edwards Lifesciences to $115 From $105, Maintains Buy Rating	MT
28/07	UBS Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $110 From $90	MT
27/07	Rothschild & Co Redburn Adjusts Edwards Lifesciences Price Target to $102 From $99, Maintains Buy Rating	MT
24/07	Edwards Lifesciences Seen Building on Catalyst Pipeline, RBC Says	MT
24/07	Deutsche Bank Adjusts Edwards Lifesciences Price Target to $103 From $100, Maintains Buy Rating	MT
24/07	Raymond James Adjusts Price Target on Edwards Lifesciences to $103 From $100, Maintains Outperform Rating	MT
24/07	Piper Sandler Adjusts Price Target on Edwards Lifesciences to $101 From $100, Maintains Overweight Rating	MT
24/07	Jefferies Adjusts Price Target on Edwards Lifesciences to $105 From $102, Maintains Buy Rating	MT
24/07	Bernstein Adjusts Price Target on Edwards Lifesciences to $99 From $96, Maintains Market Perform Rating	MT
24/07	Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87	MT
16/07	Truist Adjusts Price Target on Edwards Lifesciences to $95 From $90, Maintains Hold Rating	MT
15/07	Mizuho Adjusts Price Target on Edwards Lifesciences to $105 From $100, Maintains Outperform Rating	MT
14/07	Baird Adjusts Price Target on Edwards Lifesciences to $94 From $87, Maintains Neutral Rating	MT
14/07	Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $102 From $98, Maintains Buy Rating	MT
13/07	RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating	MT
08/07	Citigroup Adjusts Edwards Lifesciences Price Target to $110 From $101	MT
06/07	Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93	MT
30/06	BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating	MT
29/06	Edwards Lifesciences Can Sustain Strong Revenue Growth on Technological Leadership, RBC Says	MT
16/06	Edwards Lifesciences Seen Benefiting From CMS Transcatheter Aortic Valve Replacement Rule, RBC Says	MT
11/06	Edwards Lifesciences Set to Benefit from TAVR Coverage Update, RBC Says	MT
02/06	TD Cowen Adjusts Price Target on Edwards Lifesciences to $104 From $97, Maintains Buy Rating	MT
28/04	Rothschild & Co Redburn Adjusts Price Target on Edwards Lifesciences to $99 From $94, Maintains Buy Rating	MT
24/04	Mizuho Securities Adjusts Edwards Lifesciences Price Target to $100 From $95, Maintains Outperform Rating	MT
24/04	Truist Securities Adjusts Price Target on Edwards Lifesciences to $90 From $89, Maintains Hold Rating	MT

More recommendations

Other Advanced Medical Equipment & Technology

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	EDWARDS LIFESCIENCES CORPORATION					+11.92%
	THERMO FISHER SCIENTIFIC, INC.					+1.49%
	DANAHER CORPORATION					+5.5%
	INTUITIVE SURGICAL, INC.					+28.29%
	BOSTON SCIENTIFIC CORPORATION					+33.84%
	SIEMENS HEALTHINEERS AG					+14.23%
	AGILENT TECHNOLOGIES, INC.					+13.36%
	WATERS CORPORATION					+5.98%
	RESMED, INC.					+2.15%
	ILLUMINA, INC.					-7.74%
	Average					+10.90%
	Weighted average by Cap.					+11.00%